Developer docs
API playgroundTry for free, no card

Search company profiles

ARUP Laboratories

Full company profile

uuid0000y7a

Namestring
ARUP Laboratories
Legal namestring
ARUP Laboratories
Websiteurl
aruplab.com
Company typeenum
Private
Founded yearint
1984
Descriptiontext

ARUP Laboratories is a national, academic, nonprofit reference laboratory founded in 1984 as a spin-off from the University of Utah and headquartered in Salt Lake City, Utah. The company operates more than 65 individual laboratories across eight buildings in Research Park, employs between 1,001 and 5,000 people, and maintains a test directory of over 3,000 tests and test combinations. Its 150+ on-site medical directors, genetic counselors, pathologists, and specialty scientists — most of whom hold faculty appointments at the University of Utah School of Medicine — support clinical decision support through ARUP Consult, specialty testing across neurology, genetics, hematopathology, and infectious disease, and consulting via ARUP Healthcare Advisory Services.

The company generates revenue primarily through fee-for-service clinical laboratory testing billed to hospitals, integrated healthcare systems, VA/federal facilities, independent clinical laboratories, and physicians, with a secondary professional services revenue stream from pharmaceutical and biotechnology partners. Distribution is direct-to-enterprise, supported by a 24/7 Client Services center and dedicated account executives, with client interaction handled through the ARUP Connect portal. The technology stack includes AI-augmented image analysis (a Techcyte-validated deep CNN for parasitology), next-generation sequencing panels (including a first-of-its-kind myeloid malignancy panel), real-time PCR assays (e.g., dual-target measles and H5 avian influenza), and a national infectious disease surveillance dashboard built on deidentified test result data.

Recent strategic activity has been concentrated on launching new diagnostic products, building the Innovation Central Laboratory for pharma/biotech co-development, and forming partnerships to extend specimen collection (Tasso) and AI capabilities (Techcyte). The company holds CAP, CLIA, ISO 15189, and New York State Department of Health accreditations, alongside HIPAA and GDPR compliance, and is privately held as a nonprofit under the University of Utah umbrella.

Short descriptiontext

ARUP Laboratories is a nonprofit academic reference laboratory spun off from the University of Utah in 1984, offering 3,000+ tests to hospitals, health systems, and pharmaceutical/biotech partners nationwide through centralized lab operations and direct enterprise sales.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersSalt Lake City, United States
HQ citystring
Salt Lake City
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
reference laboratory services, clinical diagnostic testing, molecular diagnostics, specialty laboratory testing, laboratory consulting services
Industry3 codes
1Reference & Esoteric Testing Laboratories
CodeHLAFAMAJPrimaryYes
2Clinical Research & Trial Central Laboratories
CodeHLAFAMALPrimaryNo
3Lab Analytics, Utilization Management & Operational Intelligence
CodeHLACAMAKPrimaryNo
NAICS code2 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories62151
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
Product category
Reference Laboratory Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Clinical Laboratory Testing Services
TypeTransaction Fee
Description

ARUP operates as a national reference laboratory providing clinical laboratory testing services to healthcare systems, hospitals, and physicians. Revenue is generated through fee-for-service testing across a comprehensive test menu of over 3,000 tests and test combinations.

aruplab.com
2Pharmaceutical and Biotechnology Partner Services
TypeProfessional Services
Description

The Innovation Central Laboratory provides services to pharmaceutical, biotechnology, and industry partners including assay development, clinical trial support, central pathology review, and AI and bioinformatics solutions for diagnostic development and commercialization.

clpmag.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others
Pricing details1 tier
1Laboratory Testing Services
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Pricing is client-specific and available through ARUP Connect portal. Clients contact Client Services or their Account Executive for pricing information.

aruplab.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 7 records shown
1ARUP Consult
Description

Clinical decision support resource that empowers clinicians with robust information, algorithms, and tools for informed patient care decisions.

aruplab.com
+6 more records
Core offering1 text field

ARUP Laboratories operates as a national reference laboratory providing fee-for-service clinical diagnostic testing through a menu of more than 3,000 tests and test combinations, complemented by laboratory consulting, clinical research services, and an Innovation Central Laboratory that supports diagnostic development for pharmaceutical and biotechnology partners. Its offerings are anchored by specialty testing in neurology, genetics, hematopathology, and infectious disease, supported by the ARUP Connect client portal and ARUP Consult clinical decision support resources.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 170,000+ continuing education credits awarded annually at no cost
+2 more records
Product overview1 text field

ARUP Laboratories is a national, academic, and nonprofit reference laboratory offering a comprehensive portfolio of diagnostic products and services. The core offerings include a Laboratory Test Directory with over 3,000 tests, the ARUP Connect client portal platform, and ARUP Consult clinical decision support tool. Services span Healthcare Advisory Services for laboratory consulting, Drug and Clinical Research Services including companion diagnostics and clinical trials, and the Innovation Central Laboratory for diagnostic development. The company provides specialized testing across Neurology, Genetics, Hematopathology, and Infectious Disease specialties, supported by the ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine. Educational offerings include free continuing education through the ARUP Institute for Learning and Magnify Magazine. Recent product launches include the National Infectious Disease Test Positivity Trends Dashboard (2026), AI-Augmented Parasitology Screening Tool (2025), and blood-based biomarker assay for Alzheimer's disease (2025). The Innovation Central Laboratory supports pharmaceutical and biotech partners in validating next-generation diagnostics from concept to commercialization.

Product and service17 records
1Laboratory Test Directory
CategoryReference Laboratory Testing
2ARUP Connect
CategoryClient Portal Platform
3ARUP Consult
CategoryClinical Decision Support
4Healthcare Advisory Services
CategoryLaboratory Consulting
5Drug and Clinical Research Services
CategoryClinical Research and Pharmaceutical Services
6Innovation Central Laboratory
CategoryDiagnostic Development Services
7National Infectious Disease Test Positivity Trends Dashboard
CategoryInfectious Disease Surveillance
8AI-Augmented Parasitology Screening Tool
CategoryAI Diagnostic Tool
9At-Home Blood Testing Services
CategoryRemote Sample Collection and Testing
10Alzheimer's Disease Blood-Based Biomarker Assay
CategorySpecialty Diagnostic Assay
11Measles Virus by Qualitative NAAT
CategoryMolecular Diagnostic Assay
12Influenza A (H5) Virus by Qualitative NAAT
CategoryMolecular Diagnostic Assay
13Myeloid Malignancy Mutation Panel
CategoryNGS Diagnostic Panel
14Genome Sequencing
CategoryGenomic Sequencing Service
15GI Bacterial Panel by PCR
CategoryMolecular Diagnostic Panel
16Testing Specialties
CategorySpecialty Reference Testing
17Continuing Education and Education Resources
CategoryContinuing Education
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-26
Description

Partnership to develop at-home blood testing services using capillary blood microsamples. Enables patient-friendly blood collection outside clinical settings for clinical research applications. Tasso's proprietary technology allows patients to collect blood samples at home, which ARUP then analyzes using validated clinical assays.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-10-21
Description

Collaboration to develop AI-based solution for parasite detection in stool samples. ARUP validated Techcyte's deep convolutional neural network (CNN) technology which demonstrates higher clinical sensitivity than traditional microscopy, detecting more organisms at lower dilutions. The AI model was trained on over 4,000 samples from multiple continents.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

ARUP is an integral part of the University of Utah's academic medical ecosystem. ARUP's medical directors are active faculty members in the Department of Pathology at the University of Utah School of Medicine. The affiliation provides access to academic expertise and supports ARUP's nonprofit educational mission.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Mayo Clinic Laboratories is the nonprofit academic reference laboratory of Mayo Clinic, offering a broad specialty and esoteric test menu to hospitals and health systems nationwide. It is ARUP's closest nonprofit academic peer, with a similar model built on academic medical expertise and complex/esoteric testing.

TypeDirect peer
Description

BioReference Laboratories, an OPKO Health subsidiary, is a national full-service reference laboratory providing esoteric and routine clinical testing to hospitals, clinicians, and health systems. It directly competes with ARUP in specialty diagnostics and hospital outreach.

TypeDirect peer
Description

Quest Diagnostics is the largest U.S. for-profit reference laboratory, offering a comparable menu of routine and esoteric clinical tests to hospitals, physicians, and health systems via a national logistics network. It is the most direct for-profit competitor to ARUP's hospital-and-health-system-focused reference lab model.

TypeBroad incumbent
Description

Eurofins Scientific is a global laboratory services group offering clinical diagnostics, pharma services, and specialty testing across multiple geographies. Its clinical diagnostics division provides broad reference lab capabilities that overlap with ARUP's clinical and pharma service offerings.

TypeBroad incumbent
Description

Charles River Laboratories is a major nonclinical and clinical CRO offering research models, laboratory services, and clinical trial support. Its central laboratory and biomarker services overlap with ARUP's Drug and Clinical Research Services and Innovation Central Laboratory offerings.

TypeEmerging player
Description

Helix is a population genomics and clinical genetic testing laboratory operating a CLIA-certified, CAP-accredited next-generation sequencing platform for hereditary disease and population health. It competes with ARUP's genetics specialty in hereditary and clinical genomic testing services.

TypeDirect peer
Description

Labcorp operates one of the world's largest clinical laboratory networks, providing routine and specialty reference testing to hospitals, physicians, and biopharma clients. Its Diagnostics Laboratories segment directly overlaps ARUP's clinical reference testing business, including esoteric and molecular diagnostics.

TypeEmerging player
Description

NeoGenomics is a specialty oncology-focused reference laboratory offering molecular and genetic testing for hematologic and solid tumor cancers. It competes with ARUP's hematopathology and myeloid malignancy mutation panel offerings in the oncology specialty testing segment.

TypeEmerging player
Description

Guardant Health is a precision oncology company specializing in liquid biopsy and blood-based genomic profiling for cancer. It is comparable to ARUP's molecular and genetic testing capabilities, particularly in next-generation sequencing-based specialty diagnostics.

TypeDirect peer
Description

Sonic Healthcare USA is the U.S. arm of Sonic Healthcare, one of the world's largest medical diagnostic companies, operating regional reference laboratories serving hospitals and physicians. It competes with ARUP in esoteric reference testing, anatomic pathology, and clinical lab services.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment5 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ARUP Laboratories

Reference Laboratory Servicesaruplab.com

ARUP Laboratories is a nonprofit academic reference laboratory spun off from the University of Utah in 1984, offering 3,000+ tests to hospitals, health systems, and pharmaceutical/biotech partners nationwide through centralized lab operations and direct enterprise sales.

What ARUP Laboratories does

ARUP Laboratories is a national, academic, nonprofit reference laboratory founded in 1984 as a spin-off from the University of Utah and headquartered in Salt Lake City, Utah. The company operates more than 65 individual laboratories across eight buildings in Research Park, employs between 1,001 and 5,000 people, and maintains a test directory of over 3,000 tests and test combinations. Its 150+ on-site medical directors, genetic counselors, pathologists, and specialty scientists — most of whom hold faculty appointments at the University of Utah School of Medicine — support clinical decision support through ARUP Consult, specialty testing across neurology, genetics, hematopathology, and infectious disease, and consulting via ARUP Healthcare Advisory Services.

The company generates revenue primarily through fee-for-service clinical laboratory testing billed to hospitals, integrated healthcare systems, VA/federal facilities, independent clinical laboratories, and physicians, with a secondary professional services revenue stream from pharmaceutical and biotechnology partners. Distribution is direct-to-enterprise, supported by a 24/7 Client Services center and dedicated account executives, with client interaction handled through the ARUP Connect portal. The technology stack includes AI-augmented image analysis (a Techcyte-validated deep CNN for parasitology), next-generation sequencing panels (including a first-of-its-kind myeloid malignancy panel), real-time PCR assays (e.g., dual-target measles and H5 avian influenza), and a national infectious disease surveillance dashboard built on deidentified test result data.

Recent strategic activity has been concentrated on launching new diagnostic products, building the Innovation Central Laboratory for pharma/biotech co-development, and forming partnerships to extend specimen collection (Tasso) and AI capabilities (Techcyte). The company holds CAP, CLIA, ISO 15189, and New York State Department of Health accreditations, alongside HIPAA and GDPR compliance, and is privately held as a nonprofit under the University of Utah umbrella.

ARUP Laboratories firmographics

Firmographics
Name
ARUP Laboratories
Legal name
ARUP Laboratories
Website
https://aruplab.com
Company type
Private
Founded year
1984
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
ARUP Laboratories is a nonprofit academic reference laboratory spun off from the University of Utah in 1984, offering 3,000+ tests to hospitals, health systems, and pharmaceutical/biotech partners nationwide through centralized lab operations and direct enterprise sales.
Ownership category
akta.pro rank

ARUP Laboratories industry classification

Industry
Product category
Reference Laboratory Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)
SIC
Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Reference & Esoteric Testing Laboratories (HLAFAMAJ)
akta.pro secondary industries
Clinical Research & Trial Central Laboratories (HLAFAMAL), Lab Analytics, Utilization Management & Operational Intelligence (HLACAMAK)

Keywords

  • Reference laboratory services
  • Clinical diagnostic testing
  • Molecular diagnostics
  • Specialty laboratory testing
  • Laboratory consulting services

Where ARUP Laboratories is headquartered

Location

Headquarters

HQ city
Salt Lake City
HQ country
United States
HQ region
North America

Offices2 records

Markets served

ARUP Laboratories business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others

Revenue model

  1. Clinical Laboratory Testing Services: ARUP operates as a national reference laboratory providing clinical laboratory testing services to healthcare systems, hospitals, and physicians. Revenue is generated through fee-for-service testing across a comprehensive test menu of over 3,000 tests and test combinations.
  2. Pharmaceutical and Biotechnology Partner Services: The Innovation Central Laboratory provides services to pharmaceutical, biotechnology, and industry partners including assay development, clinical trial support, central pathology review, and AI and bioinformatics solutions for diagnostic development and commercialization.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goLaboratory Testing Services

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

ARUP Laboratories product offering

Product offering

Core offering

ARUP Laboratories operates as a national reference laboratory providing fee-for-service clinical diagnostic testing through a menu of more than 3,000 tests and test combinations, complemented by laboratory consulting, clinical research services, and an Innovation Central Laboratory that supports diagnostic development for pharmaceutical and biotechnology partners. Its offerings are anchored by specialty testing in neurology, genetics, hematopathology, and infectious disease, supported by the ARUP Connect client portal and ARUP Consult clinical decision support resources.

Product overview

ARUP Laboratories is a national, academic, and nonprofit reference laboratory offering a comprehensive portfolio of diagnostic products and services. The core offerings include a Laboratory Test Directory with over 3,000 tests, the ARUP Connect client portal platform, and ARUP Consult clinical decision support tool. Services span Healthcare Advisory Services for laboratory consulting, Drug and Clinical Research Services including companion diagnostics and clinical trials, and the Innovation Central Laboratory for diagnostic development. The company provides specialized testing across Neurology, Genetics, Hematopathology, and Infectious Disease specialties, supported by the ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine. Educational offerings include free continuing education through the ARUP Institute for Learning and Magnify Magazine. Recent product launches include the National Infectious Disease Test Positivity Trends Dashboard (2026), AI-Augmented Parasitology Screening Tool (2025), and blood-based biomarker assay for Alzheimer's disease (2025). The Innovation Central Laboratory supports pharmaceutical and biotech partners in validating next-generation diagnostics from concept to commercialization.

Differentiator

Problem solved

Functional benefit

Brands

  • ARUP Consult: Clinical decision support resource that empowers clinicians with robust information, algorithms, and tools for informed patient care decisions.
  • ARUP Institute for Learning
  • ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine
  • ARUP Healthcare Advisory Services
  • ARUP Connect
  • ARUP AnalyticsDx
  • Magnify Magazine

Products and services

  • Laboratory Test Directory
  • ARUP Connect
  • ARUP Consult
  • Healthcare Advisory Services
  • Drug and Clinical Research Services
  • Innovation Central Laboratory
  • National Infectious Disease Test Positivity Trends Dashboard
  • AI-Augmented Parasitology Screening Tool
  • At-Home Blood Testing Services
  • Alzheimer's Disease Blood-Based Biomarker Assay
  • Measles Virus by Qualitative NAAT
  • Influenza A (H5) Virus by Qualitative NAAT
  • Myeloid Malignancy Mutation Panel
  • Genome Sequencing
  • GI Bacterial Panel by PCR
  • Testing Specialties
  • Continuing Education and Education Resources

Quantifiable outcome

  • 170,000+ continuing education credits awarded annually at no cost
  • +2 more outcomes

Companies that use ARUP Laboratories

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles3 records

ARUP Laboratories technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability6 records

Feature6 records

ARUP Laboratories partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Tasso Inc.coreStrategic or Co-development Partner · 26 February 2026Partnership to develop at-home blood testing services using capillary blood microsamples. Enables patient-friendly blood collection outside clinical settings for clinical research applications. Tasso's proprietary technology allows patients to collect blood samples at home, which ARUP then analyzes using validated clinical assays.
  • TechcytecoreTechnology or Integration · 21 October 2025Collaboration to develop AI-based solution for parasite detection in stool samples. ARUP validated Techcyte's deep convolutional neural network (CNN) technology which demonstrates higher clinical sensitivity than traditional microscopy, detecting more organisms at lower dilutions. The AI model was trained on over 4,000 samples from multiple continents.
  • University of Utah School of MedicinecoreStrategic or Co-development PartnerARUP is an integral part of the University of Utah's academic medical ecosystem. ARUP's medical directors are active faculty members in the Department of Pathology at the University of Utah School of Medicine. The affiliation provides access to academic expertise and supports ARUP's nonprofit educational mission.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

ARUP Laboratories competitors and assessment

Company assessment

Direct peers

  • Mayo Clinic Laboratories: Mayo Clinic Laboratories is the nonprofit academic reference laboratory of Mayo Clinic, offering a broad specialty and esoteric test menu to hospitals and health systems nationwide. It is ARUP's closest nonprofit academic peer, with a similar model built on academic medical expertise and complex/esoteric testing.
  • BioReference Laboratories: BioReference Laboratories, an OPKO Health subsidiary, is a national full-service reference laboratory providing esoteric and routine clinical testing to hospitals, clinicians, and health systems. It directly competes with ARUP in specialty diagnostics and hospital outreach.
  • Quest Diagnostics: Quest Diagnostics is the largest U.S. for-profit reference laboratory, offering a comparable menu of routine and esoteric clinical tests to hospitals, physicians, and health systems via a national logistics network. It is the most direct for-profit competitor to ARUP's hospital-and-health-system-focused reference lab model.
  • Laboratory Corporation of America (Labcorp): Labcorp operates one of the world's largest clinical laboratory networks, providing routine and specialty reference testing to hospitals, physicians, and biopharma clients. Its Diagnostics Laboratories segment directly overlaps ARUP's clinical reference testing business, including esoteric and molecular diagnostics.
  • Sonic Healthcare USA: Sonic Healthcare USA is the U.S. arm of Sonic Healthcare, one of the world's largest medical diagnostic companies, operating regional reference laboratories serving hospitals and physicians. It competes with ARUP in esoteric reference testing, anatomic pathology, and clinical lab services.

Broad incumbents

  • Eurofins Scientific: Eurofins Scientific is a global laboratory services group offering clinical diagnostics, pharma services, and specialty testing across multiple geographies. Its clinical diagnostics division provides broad reference lab capabilities that overlap with ARUP's clinical and pharma service offerings.
  • Charles River Laboratories: Charles River Laboratories is a major nonclinical and clinical CRO offering research models, laboratory services, and clinical trial support. Its central laboratory and biomarker services overlap with ARUP's Drug and Clinical Research Services and Innovation Central Laboratory offerings.

Emerging players

  • Helix: Helix is a population genomics and clinical genetic testing laboratory operating a CLIA-certified, CAP-accredited next-generation sequencing platform for hereditary disease and population health. It competes with ARUP's genetics specialty in hereditary and clinical genomic testing services.
  • NeoGenomics: NeoGenomics is a specialty oncology-focused reference laboratory offering molecular and genetic testing for hematologic and solid tumor cancers. It competes with ARUP's hematopathology and myeloid malignancy mutation panel offerings in the oncology specialty testing segment.
  • Guardant Health: Guardant Health is a precision oncology company specializing in liquid biopsy and blood-based genomic profiling for cancer. It is comparable to ARUP's molecular and genetic testing capabilities, particularly in next-generation sequencing-based specialty diagnostics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

ARUP Laboratories social profiles

Digital presence

ARUP Laboratories compliance and trust

Trust signal

Compliance5 records

ARUP Laboratories financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ARUP Laboratories leadership team

Management profile

Number of profiles

Profiles1 record

ARUP Laboratories funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ARUP Laboratories M&A and investment

M&A and investment

M&A

Investments5 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ARUP Laboratories

What does ARUP Laboratories do?

ARUP Laboratories operates as a national reference laboratory providing fee-for-service clinical diagnostic testing through a menu of more than 3,000 tests and test combinations, complemented by laboratory consulting, clinical research services, and an Innovation Central Laboratory that supports diagnostic development for pharmaceutical and biotechnology partners. Its offerings are anchored by specialty testing in neurology, genetics, hematopathology, and infectious disease, supported by the ARUP Connect client portal and ARUP Consult clinical decision support resources.

Is ARUP Laboratories a public or private company?

ARUP Laboratories is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was ARUP Laboratories founded?

ARUP Laboratories was founded in 1984. It employs 1,001 to 5,000 people.

Where is ARUP Laboratories based?

ARUP Laboratories is headquartered in Salt Lake City, United States, in the North America region.

How does ARUP Laboratories make money?

Two revenue lines are on record. Clinical Laboratory Testing Services are the primary driver. The others are pharmaceutical and Biotechnology Partner Services.

Who are ARUP Laboratories's main competitors?

Direct peers on record are Mayo Clinic Laboratories, BioReference Laboratories, Quest Diagnostics, Laboratory Corporation of America (Labcorp) and Sonic Healthcare USA. Broad incumbents are Eurofins Scientific and Charles River Laboratories. Emerging players are Helix, NeoGenomics and Guardant Health.

Does ARUP Laboratories have an API?

No public API is recorded for ARUP Laboratories.

What industry is ARUP Laboratories in?

ARUP Laboratories's product category is Reference Laboratory Services. Its primary akta.pro industry code is HLAFAMAJ, Reference & Esoteric Testing Laboratories, with a secondary code of HLAFAMAL, Clinical Research & Trial Central Laboratories. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireARUP Artificial Intelligence Project Selected for Redtail AI Factory Challenge ProjectARUP Laboratories was selected for the second cohort of Redtail AI Factory challenge projects with its project "Scaling EventHorizon with Redtail: A Foundation Model for Clinical Flow Cytometry." The award provides access to Redtail's supercomputing infrastructure to accelerate development of an AI model for analyzing flow cytometry data, aiming to improve diagnostic accuracy and reduce turnaround times.PR NewswireGroundbreaking ARUP Research Clarifies Clinical Value of Atypical Cell-Free DNA Screening ResultsARUP Laboratories researchers analyzed over 200 cases with atypical prenatal cell-free DNA screening results and follow-up testing, published in Genetics in Medicine. The study found 50% of atypical cases had at least one abnormal result, with 55 pathogenic findings, indicating atypical results warrant clinical investigation.AijournARUP Laboratories Adds Cyclospora Data to Infectious Disease Dashboard Amid National OutbreakARUP Laboratories has added Cyclospora test positivity data to its National Infectious Disease Test Positivity Trends Dashboard, responding to client interest driven by the scale and rapid growth of the ongoing national cyclosporiasis outbreak. As of July 28, 2026, the CDC had reported 6,707 laboratory-confirmed cases across 45 states, with over 11,500 additional cases under investigation. The dashboard, launched in May 2026, provides near-real-time visibility into disease activity for clinicians, laboratories, and public health professionals to complement traditional public health reporting.PR NewswireARUP Laboratories Adds Cyclospora Data to Infectious Disease Dashboard Amid National OutbreakARUP Laboratories has expanded its National Infectious Disease Test Positivity Trends Dashboard to include Cyclospora test positivity data in response to a significant national cyclosporiasis outbreak. The CDC has reported 6,707 laboratory-confirmed cases across 45 states as of July 28, 2026, with over 11,500 additional cases still under investigation. The dashboard, which launched in May 2026 as the first public tracking tool developed by a U.S. reference laboratory, provides near-real-time surveillance data to help clinicians and public health professionals monitor disease activity.YahooARUP introduces spectral flow assay for multiple myelomaARUP Laboratories has launched the CLARISPECT Multiple Myeloma MRD by Spectral Flow Cytometry assay, a clinical diagnostic test that provides detailed minimal residual disease profiling for multiple myeloma patients. The test uses spectral flow cytometry technology to simultaneously assess 18 markers in a single tube configuration, offering higher sensitivity than conventional flow cytometry methods and detecting 14 neoplastic cells in a population of five million analyzed cells with 95% confidence. ARUP plans to further expand its MRD spectral flow cytometry testing suite as part of its commitment to diagnostic innovation and patient care.Medical Device NetworkARUP introduces spectral flow assay for multiple myelomaARUP Laboratories has launched the CLARISPECT Multiple Myeloma MRD by Spectral Flow Cytometry assay, which assesses 18 markers in a single tube to detect minimal residual disease in multiple myeloma patients. The test uses spectral flow cytometry technology capable of identifying 14 neoplastic cells among five million analyzed cells with 95% confidence, offering higher sensitivity than conventional flow cytometry methods. ARUP states this will enable earlier detection of disease reemergence, facilitating more informed treatment decisions at earlier timepoints.AijournARUP Launches First Clinical Spectral Flow Cytometry Assay for MRD Assessment in Multiple MyelomaARUP Laboratories announced the launch of ARUP CLARISPECT Multiple Myeloma MRD, a spectral flow cytometry assay for minimal residual disease assessment in multiple myeloma patients, making it the first large reference laboratory in the United States to offer spectral flow technology for clinical use. The assay can detect as few as 14 neoplastic cells in a population of 5 million analyzed cells with 95% confidence by assessing 18 markers simultaneously. ARUP plans to expand its MRD spectral flow cytometry testing suite beyond this initial launch.PR NewswireARUP Launches First Clinical Spectral Flow Cytometry Assay for MRD Assessment in Multiple MyelomaARUP Laboratories announced the launch of ARUP CLARISPECT Multiple Myeloma MRD by Spectral Flow Cytometry, becoming the first large reference laboratory in the United States to offer spectral flow technology for clinical use. The assay provides deeper minimal residual disease profiling with greater sensitivity than conventional flow cytometry, detecting as few as 14 neoplastic cells in 5 million analyzed cells with 95% confidence while requiring less specimen volume. ARUP will continue expanding its MRD by spectral flow cytometry testing suite as part of its commitment to innovation in diagnostic medicine.PR NewswireClinical Labs Review Proposed Legislation To Modernize Oversight of Lab-Developed Tests Under CLIAFederal legislation called the Enhancing CLIA Act was introduced on May 19, 2026 by Rep. Neal Dunn to modernize oversight of laboratory-developed tests (LDTs) under the Clinical Laboratory Improvement Amendments framework, representing the first legislative response following a 2025 court decision in ACLA v. FDA that vacated the FDA's rule regulating LDTs as medical devices. The bill's key provisions include reaffirming CMS authority over LDTs, establishing a public database for LDT information, requiring reporting of test errors causing serious harm, and delaying implementation for two years with a voluntary pathway for existing clearances. ARUP Laboratories, a leading national reference laboratory, is actively reviewing the legislation and has engaged in prior advocacy on LDT policy.GlobeNewswireCapillary Blood Collection Devices Market to Value USD 4.86 Billion by 2035, Expanding at an 8.26% CAGR – SNS InsiderSNS Insider released a market research report projecting the global capillary blood collection devices market to grow from USD 2.20 billion in 2025 to USD 4.86 billion by 2035, expanding at a CAGR of 8.26%, driven by rising diabetes prevalence, point-of-care diagnostics expansion, and increasing home healthcare adoption. The report highlights recent partnerships including Tasso Inc. and ARUP Laboratories validating clinical assays using capillary blood microsamples, and BD and Babson Diagnostics expanding fingertip blood collection technologies for U.S. healthcare systems. North America led the market in 2023 with a 32.2% share, while the Asia-Pacific region is identified as the fastest-growing market.